NCT00406159

Brief Summary

PURPOSE The purpose of this investigation is to evaluate the cognitive and behavioral effects of Hyperbaric Oxygenation Therapy in children who present with a diagnosis of autism spectrum disorder. HYPOTHESIS

  1. 1.Hyperbaric Oxygenation Therapy will be safe to use with children with autism.
  2. 2.Hyperbaric Oxygenation Therapy will have a statistically significant effect on the symptoms of autism.
  3. 3.Hyperbaric Oxygenation Therapy will have a clinically significant observable effect on the overt symptoms of autism.
  4. 4.The decreases in the symptoms of autism will correlate positively with the number of Hyperbaric Oxygenation Therapy sessions.
  5. 5.Treatment gains obtained from Hyperbaric Oxygenation Therapy will be maintained at follow-up, post 40 treatment sessions.
  6. 6.Provide further evidence for the safety of Hyperbaric Oxygenation Therapy in children with autism.
  7. 7.To quantitatively assess the effects of Hyperbaric Oxygenation Therapy on behavioral and cognitive symptoms of autism before, during, and after treatment.
  8. 8.Identify number of treatments required to reach therapeutic effects.
  9. 9.Identify the length and durability of treatment effect and maintenance.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at P25-P50 for phase_1

Timeline
Completed

Started Nov 2006

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2006

Completed
28 days until next milestone

First Submitted

Initial submission to the registry

November 29, 2006

Completed
5 days until next milestone

First Posted

Study publicly available on registry

December 4, 2006

Completed
9 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2007

Completed
Last Updated

August 7, 2009

Status Verified

August 1, 2009

First QC Date

November 29, 2006

Last Update Submit

August 6, 2009

Conditions

Keywords

AutismHyperbaric Oxygen TherapyBehavioral assessments

Outcome Measures

Primary Outcomes (15)

  • Standardized Measures

  • In addition to the direct measures of behavior described above, standardized intelligence and adaptive assessments will be conducted prior to the initiation of HBOT. These will include:

  • ADI/ADOS

  • WPPSI-III (2-6 years) /WASI (6+ years)

  • Vineland Adaptive Behavior Scale (VABS)

  • Subjective Questionnaires

  • Aberrant Behavior Checklist

  • Clinical Global Impression

  • ATEC

  • Selected sections of the APEQ

  • BRIEF

  • Parenting Stress Index

  • Repetitive Behavior Scale

  • A side effect questionnaire

  • Thoughtful House Caregiver diary

Interventions

Eligibility Criteria

Age2 Years - 10 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • Male and female children 2-10 years diagnosed with autism, PDD, or Aspergers
  • No anticipated changes in treatment for the study duration (e.g., diet, nutrients)
  • No additional biomedical treatments started 6 weeks prior to enrollment
  • No changes in dietary management for 3 months prior to enrollment
  • Access to Thoughtful House on a daily basis, or as necessary for the study participation
  • In addition, the child participant must be:
  • Ambulatory or require minimum support walking, per parent
  • Able to sit still for 5 minutes or longer with a preferred toy item, per parent
  • Adequate vision and hearing for the purposes of test administration, per parent
  • Adequate arm-hand-finger coordination (i.e., able to point) for learning and cognitive tasks used in outcome measurement, per parent
  • Stable and controlled medical disorder
  • Under the care of a caregiver willing to participate by attending regularly scheduled appointments and completing the necessary measures

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Medical Center at Thoughtful House

Austin, Texas, 78746, United States

Location

Related Publications (2)

  • Rossignol DA, Rossignol LW. Hyperbaric oxygen therapy may improve symptoms in autistic children. Med Hypotheses. 2006;67(2):216-28. doi: 10.1016/j.mehy.2006.02.009. Epub 2006 Mar 22.

  • Jepson B, Granpeesheh D, Tarbox J, Olive ML, Stott C, Braud S, Yoo JH, Wakefield A, Allen MS. Controlled evaluation of the effects of hyperbaric oxygen therapy on the behavior of 16 children with autism spectrum disorders. J Autism Dev Disord. 2011 May;41(5):575-88. doi: 10.1007/s10803-010-1075-y.

MeSH Terms

Conditions

Autistic Disorder

Interventions

Hyperbaric Oxygenation

Condition Hierarchy (Ancestors)

Autism Spectrum DisorderChild Development Disorders, PervasiveNeurodevelopmental DisordersMental Disorders

Intervention Hierarchy (Ancestors)

Oxygen Inhalation TherapyRespiratory TherapyTherapeutics

Study Officials

  • Andrew Wakefield, MD

    Thoughtful House Center for Children

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
phase 1
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER

Study Record Dates

First Submitted

November 29, 2006

First Posted

December 4, 2006

Study Start

November 1, 2006

Study Completion

September 1, 2007

Last Updated

August 7, 2009

Record last verified: 2009-08

Locations